Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Free-pricing holiday for new drugs in Germany a potential target

This article was originally published in SRA

Executive Summary

Drug companies in Germany could see lower prices for their new products take effect sooner and potential delays to launch if German policymakers do away with the 12-month grace period of free pricing for new drugs before the outcome of early benefit assessments and pricing talks kick in. The warning comes from Wolfgang Kaesbach, a former head of the pharmaceutical department of the GKV, the national association of statutory health insurers.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel